Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cb9f654ff-pvkqz Total loading time: 0 Render date: 2025-08-08T20:56:13.100Z Has data issue: false hasContentIssue false

19 - Combining hypothermia with other therapies for neonatal neuroprotection

from Section 3 - The future

Published online by Cambridge University Press:  05 March 2013

By
Faye S. Silverstein  and
John D. Barks
Edited by
A. David Edwards ,
Denis V. Azzopardi  and
Alistair J. Gunn
A. David Edwards
Affiliation:
Institute of Reproductive and Developmental Biology, Imperial College, London
Denis V. Azzopardi
Affiliation:
Institute of Reproductive and Developmental Biology, Imperial College, London
Alistair J. Gunn
Affiliation:
School of Medical Sciences, University of Auckland
Get access

Summary

Introduction

There is compelling evidence that therapeutic hypothermia confers significant benefit in term neonates with post-asphyxial encephalopathy. Yet, over 40% of treated infants have poor neurodevelopmental outcomes and there is an urgent need to identify treatments that effectively supplement the beneficial effects of hypothermia. This chapter focuses on discussion of clinically available therapeutic agents that could be administered in conjunction with hypothermia and that have the potential to augment the neuroprotective efficacy of cooling. Target populations for combination therapies include both infants who have poor outcomes with current treatments and also infants who are ultimately classified as having “good” outcomes, but who could have the potential for better long-term neurobehavioural function.

There is an inevitable delay period before therapeutic hypothermia can be started. Since time to onset of cooling is a major determinant of neuroprotective efficacy experimentally, agents that extended the duration of the therapeutic window for initiation of hypothermia would be desirable. Supplemental therapies could conceivably be administered prenatally, intra-partum, in conjunction with resuscitation, during post-resuscitation stabilization, or during transport to a neonatal intensive care unit. For any treatment administered more broadly to “at risk” neonates, before a diagnosis of encephalopathy, safety would be a critical pre-requisite and adequate documentation of safety in this population would inevitably be very challenging. For agents administered to symptomatic neonates, concurrently with onset of cooling, it would be essential to analyze drug/hypothermia interactions and take into account the impact of acute kidney or liver injury on drug pharmacokinetics. As more is understood both about endogenous mechanisms of brain repair and the mechanisms that underlie the beneficial effects of hypothermia, it may also become feasible to target therapies specifically to replicate or strengthen these mechanisms to enhance recovery after the end of hypothermia.

Information

Type
Chapter
Information
Neonatal Neural Rescue
A Clinical Guide
 , pp. 208 - 218
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Evans, DJ, Levene, MI, Tsakmakis, M. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database Syst Rev 2007;18;(3):CD001240.Google Scholar
Silverstein, FS, Jensen, FE. Neonatal seizures. Ann Neurol 2007;62:112–20.CrossRefGoogle ScholarPubMed
Silverstein, FS. Do seizures contribute to neonatal hypoxic-ischemic brain injury?J Pediatr 2009;155:305–6.CrossRefGoogle ScholarPubMed
Bergey, GK, Swaiman, KF, Schrier, BK, et al. Adverse effects of phenobarbital on morphological and biochemical development of fetal mouse spinal cord neurons in culture. Ann Neurol 1981;9:584–9.CrossRefGoogle ScholarPubMed
Bittigau, P, Sifringer, M, Genz, K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 2002;99:15089–94.CrossRefGoogle ScholarPubMed
Stefovska, VG, Uckermann, O, Czuczwar, M, et al. Sedative and anticonvulsant drugs suppress postnatal neurogenesis. Ann Neurol 2008;64:434–45.CrossRefGoogle ScholarPubMed
Holmes, GL. The long-term effects of neonatal seizures. Clin Perinatol 2009;36:901–14.CrossRefGoogle ScholarPubMed
Wirrell, EC, Armstrong, EA, Osman, LD, et al. Prolonged seizures exacerbate perinatal hypoxic-ischemic brain damage. Pediatr Res 2001;50:445–54.CrossRefGoogle ScholarPubMed
Yager, JY, Armstrong, EA, Jaharus, C, et al. Preventing hyperthermia decreases brain damage following neonatal hypoxic-ischemic seizures. Brain Res 2004;1011:48–57.CrossRefGoogle ScholarPubMed
Gunn, AJ, Bennet, L, Gunning, MI, et al. Cerebral hypothermia is not neuroprotective when started after postischemic seizures in fetal sheep. Pediatr Res 1999;46:274–80.CrossRefGoogle Scholar
Miller, SP, Weiss, J, Barnwell, A, et al. Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology 2002;58:542–8.CrossRefGoogle ScholarPubMed
Glass, HC, Glidden, D, Jeremy, RJ, et al. Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. J Pediatr 2009;155:318–23.CrossRefGoogle ScholarPubMed
van Rooij, LGM, de Vries, LS, Handryastuti, S, et al. Neurodevelopmental outcome in term infants with status epilepticus detected with amplitude-integrated electroencephalography. Pediatrics 2007;120:e354–63.CrossRefGoogle ScholarPubMed
Wyatt, JS, Gluckman, PD, Liu, PY, et al. Determinants of outcomes after headcooling for neonatal encephalopathy. Pediatrics 2007;119:912–21.CrossRefGoogle ScholarPubMed
Rice, JE, Vannucci, RC, Brierley, JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981;9:131–41.CrossRefGoogle ScholarPubMed
Liu, YQ, Barks, JDE, Xu, G, et al. Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 2004;35:1460–5.CrossRefGoogle ScholarPubMed
Barks, JD, Liu, YQ, Shangguan, Y, et al. Phenobarbital augments hypothermic neuroprotection. Pediatr Res 2010;67:532–7.CrossRefGoogle ScholarPubMed
Hall, RT, Hall, FK, Daily, DK. High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up. J Pediatr 1998;132:345–8.CrossRefGoogle ScholarPubMed
Liu, YQ, Shangguan, Y, Barks, JD, et al. Levetiracetam and brief hypothermia confer sustained neuroprotection in a neonatal rat model of hypoxic-ischemic brain injury. Society for Pediatric Research Annual Meeting, Abstract 1365.3, May 1, 2010.
Lynch, BA, Lambeng, N, Nocka, K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 2004;101:9861–6.CrossRefGoogle ScholarPubMed
Manthey, D, Asimiadou, S, Stefovska, V, et al. Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol 2005;193:497–503.CrossRefGoogle Scholar
Calabresi, P, Cupini, LM, Centonze, D, et al. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann Neurol 2003;53:693–702.CrossRefGoogle ScholarPubMed
Kaandorp, JJ, Benders, MJ, Rademaker, CM, et al. Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study. BMC Pregnancy Childbirth 2010;10:8.CrossRefGoogle ScholarPubMed
Filippi, L, la Marca, G, Fiorini, P, et al. Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy. Epilepsia 2009;50:2355–61.CrossRefGoogle ScholarPubMed
Filippi, L, Poggi, C, la Marca, G, et al. Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: a safety study. J Pediatr 2010;157:361–6.CrossRefGoogle ScholarPubMed
Silverstein, FS, Ferriero, DM. Off-label use of anticonvulsants for treatment of neonatal seizures. Ped Neurol 2008;39:77–9.CrossRefGoogle ScholarPubMed
Ma, D, Hossain, M, Chow, A, et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005;58:182–93.CrossRefGoogle ScholarPubMed
Martin, JL, Ma, D, Hossain, M, et al. Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat. Br J Anaesth 2007;98:236–40.CrossRefGoogle ScholarPubMed
Hobbs, C, Thoresen, M, Tucker, A, et al. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke 2008;39:1307–13.CrossRefGoogle ScholarPubMed
Thoresen, M, Hobbs, CE, Wood, T, et al. Cooling combined with immediate or delayed xenon inhalation provides equivalent long-term neuroprotection after neonatal hypoxia–ischemia. J Cereb Blood Flow Metab 2009;29:707–14.CrossRefGoogle ScholarPubMed
Chakkarapani, E, Dingley, J, Liu, X, et al. Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs. Ann Neurol 2010;68:330–41.CrossRefGoogle ScholarPubMed
Jatana, M, Singh, I, Singh, AK, Jenkins, D. Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 2006;59:684–9.CrossRefGoogle ScholarPubMed
Hobbs, CE, Oorschot, DE. Neonatal rat hypoxia-ischemia: long-term rescue of striatal neurons and motor skills by combined antioxidant-hypothermia treatment. Brain Pathol 2008;18:443–54.CrossRefGoogle ScholarPubMed
Wang, X, Svedin, P, Nie, C, et al. N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury. Ann Neurol 2007;61:263–71.CrossRefGoogle ScholarPubMed
Palmer, C, Vannucci, RC, Towfighi, J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr Res 1990;27:332–6.CrossRefGoogle ScholarPubMed
Chaudhari, T, McGuire, W. Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic-ischaemic encephalopathy. Cochrane Database Syst Rev 2008;16;(2):CD006817.Google Scholar
Torrance, HL, Benders, MJ, Derks, JB, et al. Maternal allopurinol during fetal hypoxia lowers cord blood levels of the brain injury marker S-100B. Pediatrics 2009;124:350–7.CrossRefGoogle ScholarPubMed
Meloni, BP, Campbell, K, Zhu, H, Knuckey, NW. In search of clinical neuroprotection after brain ischemia: the case for mild hypothermia (35 degrees C) and magnesium. Stroke 2009;40:2236–40.CrossRefGoogle Scholar
Bhat, MA, Charoo, BA, Bhat, JI, et al. Magnesium sulfate in severe perinatal asphyxia: a randomized, placebo-controlled trial. Pediatrics 2009;123:e764–9.CrossRefGoogle ScholarPubMed
Ma, D, Rajakumaraswamy, N, Maze, M. alpha2A-adrenoceptor agonists: shedding light on neuroprotection?Br Med Bull 2005;71:77–92.CrossRefGoogle Scholar
Paris, A, Mantz, J, Tonner, PH, et al. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype. Anesth Analg 2006;102:456–61.CrossRefGoogle ScholarPubMed
Tobias, JD. Bradycardia during dexmedetomidine and therapeutic hypothermia. J Intensive Care Med 2008;23:403–8.CrossRefGoogle ScholarPubMed
Carloni, S, Perrone, S, Buonocore, G, et al. Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res 2008;44:157–64.CrossRefGoogle ScholarPubMed
Lin, MT, Chuang, JI. Melatonin potentiates 5-HT(1A) receptor activation in rat hypothalamus and results in hypothermia. J Pineal Res 2002;33:14–9.CrossRefGoogle ScholarPubMed
Tooley, JR, Satas, S, Porter, H, et al. Head cooling with mild systemic hypothermia in anesthetized piglets is neuroprotective. Ann Neurol 2003;53:65–72.CrossRefGoogle ScholarPubMed
Creeley, CE, Olney, JW. The young: neuroapoptosis induced by anesthetics and what to do about it. Anesth Analg 2010;110:442–8.CrossRefGoogle Scholar
McPherson, RJ, Juul, SE. Erythropoietin for infants with hypoxic-ischemic encephalopathy. Curr Opin Pediatr 2010;22:139–45.CrossRefGoogle ScholarPubMed
Zhu, C, Kang, W, Xu, F, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009;124:e218-e226.CrossRefGoogle ScholarPubMed
Guan, J, Gunn, AJ, Sirimanne, ES, et al. The window of opportunity for neuronal rescue with insulin-like growth factor-1 after hypoxia-ischemia in rats is critically modulated by cerebral temperature during recovery. J Cereb Blood Flow Metab 2000;20:513–9.CrossRefGoogle ScholarPubMed
Cariou, A, Claessens, YE, Pène, F, et al. High-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study. Resuscitation 2008;76:397–404.CrossRefGoogle ScholarPubMed
D’Cruz, BJ, Fertig, KC, Filiano, AJ, et al. Hypothermic reperfusion after cardiac arrest augments brain-derived neurotrophic factor activation. J Cereb Blood Flow Metab 2002;22:843–51.CrossRefGoogle ScholarPubMed
Schmitt, KR, Boato, F, Diestel, A, et al. Hypothermia-induced neurite outgrowth is mediated by tumor necrosis factor-alpha. Brain Pathol 2010;20:771–9.CrossRefGoogle ScholarPubMed
Tang, XN, Liu, L, Yenari, MA. Combination therapy with hypothermia for treatment of cerebral ischemia. J Neurotrauma 2009;26:325–31.CrossRefGoogle ScholarPubMed
Bona, E, Hagberg, H, Løberg, EM, et al. Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short- and long-term outcome. Pediatr Res 1998;43:738–45.CrossRefGoogle ScholarPubMed
Siegel, C, Turtzo, C, McCullough, LD. Sex differences in cerebral ischemia: possible molecular mechanisms. J Neurosci Res 2010;88:2765–74.CrossRefGoogle ScholarPubMed

Accessibility standard: Unknown

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×